WO1998001440B1 - Compositions pharmaceutiques antivirales contenant des composes 1,2-dithiaheterocycliques satures et utilisation de ces compositions - Google Patents

Compositions pharmaceutiques antivirales contenant des composes 1,2-dithiaheterocycliques satures et utilisation de ces compositions

Info

Publication number
WO1998001440B1
WO1998001440B1 PCT/US1997/010870 US9710870W WO9801440B1 WO 1998001440 B1 WO1998001440 B1 WO 1998001440B1 US 9710870 W US9710870 W US 9710870W WO 9801440 B1 WO9801440 B1 WO 9801440B1
Authority
WO
WIPO (PCT)
Prior art keywords
compound
pharmaceutical composition
saturated
dithiaheterocyclic
pharmaceutically acceptable
Prior art date
Application number
PCT/US1997/010870
Other languages
English (en)
Other versions
WO1998001440A3 (fr
WO1998001440A9 (fr
WO1998001440A2 (fr
Filing date
Publication date
Application filed filed Critical
Priority to US09/214,331 priority Critical patent/US6046228A/en
Priority to AU44085/97A priority patent/AU737038B2/en
Priority to EP97942372A priority patent/EP1023284B1/fr
Priority to AT97942372T priority patent/ATE310738T1/de
Priority to DE69734734T priority patent/DE69734734D1/de
Publication of WO1998001440A2 publication Critical patent/WO1998001440A2/fr
Publication of WO1998001440A3 publication Critical patent/WO1998001440A3/fr
Publication of WO1998001440B1 publication Critical patent/WO1998001440B1/fr
Publication of WO1998001440A9 publication Critical patent/WO1998001440A9/fr

Links

Abstract

La présente invention concerne des compositions pharmaceutiques contenant des composés 1,2-dithiahétérocycliques saturés présentant une activité antivirale. L'invention concerne également un matériel contenant la compositions pharmaceutique. L'invention concerne aussi sur des thérapies permettant de soigner ou de prévenir une affection virale au moyen de ces compositions. L'invention concerne enfin des procédés d'inactivation rétrovirale dans un fluide organique.
PCT/US1997/010870 1996-07-05 1997-07-03 Compositions pharmaceutiques antivirales contenant des composes 1,2-dithiaheterocycliques satures et utilisation de ces compositions WO1998001440A2 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
US09/214,331 US6046228A (en) 1996-07-05 1997-07-03 Anti-viral pharmaceutical compositions containing saturated 1,2-dithiaheterocyclic compounds and uses thereof
AU44085/97A AU737038B2 (en) 1996-07-05 1997-07-03 Anti-viral pharmaceutical compositions containing saturated 1,2-dithiaheterocyclic compounds and uses thereof
EP97942372A EP1023284B1 (fr) 1996-07-05 1997-07-03 Compositions pharmaceutiques antivirales contenant des composes 1,2-dithiaheterocycliques satures
AT97942372T ATE310738T1 (de) 1996-07-05 1997-07-03 Gesättigte 1,2-dithiaheterocyclische verbindungen enthaltende antivirale pharmazeutische zubereitungen
DE69734734T DE69734734D1 (de) 1996-07-05 1997-07-03 Gesättigte 1,2-dithiaheterocyclische verbindungen enthaltende antivirale pharmazeutische zubereitungen

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2166596P 1996-07-05 1996-07-05
US60/021,665 1996-07-05

Publications (4)

Publication Number Publication Date
WO1998001440A2 WO1998001440A2 (fr) 1998-01-15
WO1998001440A3 WO1998001440A3 (fr) 1998-05-14
WO1998001440B1 true WO1998001440B1 (fr) 1998-06-11
WO1998001440A9 WO1998001440A9 (fr) 1998-07-16

Family

ID=21805475

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1997/010870 WO1998001440A2 (fr) 1996-07-05 1997-07-03 Compositions pharmaceutiques antivirales contenant des composes 1,2-dithiaheterocycliques satures et utilisation de ces compositions

Country Status (7)

Country Link
US (1) US6046228A (fr)
EP (1) EP1023284B1 (fr)
AT (1) ATE310738T1 (fr)
AU (1) AU737038B2 (fr)
CA (1) CA2260128A1 (fr)
DE (1) DE69734734D1 (fr)
WO (1) WO1998001440A2 (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6417180B1 (en) * 1998-10-07 2002-07-09 University Of Massachusetts Zinc finger-reactive antimicrobial compounds
EP1486495B1 (fr) * 1998-10-26 2009-12-09 The Research Foundation of State University of New York Sels de dérives de l'acide lipoique et leur utilisation dans le traitement des maladies
US6204288B1 (en) 1999-03-08 2001-03-20 The University Of Mississippi 1,2-dithiolane derivatives
US6288106B1 (en) * 1999-05-25 2001-09-11 Chronorx, Llc Processes for the synthesis and use of various α-lipoic acid complexes
WO2001025226A1 (fr) * 1999-10-05 2001-04-12 Bethesda Pharmaceuticals, Inc. Derives de dithiolane
US6664287B2 (en) * 2000-03-15 2003-12-16 Bethesda Pharmaceuticals, Inc. Antioxidants
US6638915B1 (en) 2000-06-30 2003-10-28 Harold Killam Anti-viral composition
EP1172110A3 (fr) * 2000-07-07 2003-09-17 Basf Aktiengesellschaft Utilisation de l'acide lipoique pour augmenter la biodisponibilité de sels minéraux
AU2002322721B2 (en) 2001-08-03 2009-01-08 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Acylthiols and component thiol compositions as anti-HIV and anti-retroviral agents
TWI281916B (en) * 2001-10-25 2007-06-01 Lilly Co Eli Antitumor compounds and methods
DE10163836A1 (de) * 2001-12-22 2003-07-10 Friz Biochem Gmbh Multifunktionales Reagenz zur Synthese von thiolmodifizierten Oligomeren
US7101676B2 (en) * 2002-01-11 2006-09-05 Douglas Buechter Methods for identifying compounds which inhibit binding of nucleocapsid 7 protein to HIV-1 RNA
AU2003279916A1 (en) * 2002-10-08 2004-05-04 The Government Of The Usa As Represented By The Secretary Of The Dept. Of Health And Human Services Identification of anti-hiv compounds inhibiting virus assembly and binding of nucleocapsid protein to nucleic acid
JP2010520333A (ja) 2007-03-01 2010-06-10 セダーズ−シナイ メディカル センター 〔1,2〕−ジチオラン部分を含有する抗酸化剤重合体およびその使用
US9028874B2 (en) 2008-01-03 2015-05-12 Cedars-Sinai Medical Center Antioxidant nanosphere comprising [1,2]-dithiolane moieties
US8603531B2 (en) 2008-06-02 2013-12-10 Cedars-Sinai Medical Center Nanometer-sized prodrugs of NSAIDs
ES2529060T3 (es) 2008-11-24 2015-02-16 Cedars-Sinai Medical Center Derivados antioxidantes de la camptotecina y nanoesferas antineoplásicas antioxidantes de los mismos
US20130096092A1 (en) 2010-06-10 2013-04-18 Health And Human Services Thioether prodrug compositions as anti-hiv and anti-retroviral agents
CA2832109C (fr) 2011-06-10 2021-07-06 Oregon Health & Science University Glycoproteines de cmv et vecteurs recombinants cmv
JP6480340B2 (ja) 2012-11-15 2019-03-06 ブランデイズ ユニバーシティー 環状ジスルフィドを用いるシステイン残基のテザリング
KR20150092243A (ko) * 2012-12-06 2015-08-12 머크 샤프 앤드 돔 코포레이션 뉴클레오시드 키나제 우회 조성물 및 방법
WO2015035003A1 (fr) 2013-09-05 2015-03-12 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Compositions de promédicament thioéther utilisées comme agents anti-vih et antirétroviraux
WO2017017669A1 (fr) * 2015-07-24 2017-02-02 Aposense Ltd. Promédicaments et méthodes associées
WO2017031226A1 (fr) 2015-08-18 2017-02-23 Brandeis University Résidus de cystéine d'attache utilisant des disulfures cycliques
WO2022049219A1 (fr) 2020-09-02 2022-03-10 Université De Genève Méthodes de traitement d'une infection virale

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3158621A (en) * 1962-06-20 1964-11-24 American Cyanamid Co Dithiolium compounds and their preparation
CH656382A5 (de) * 1983-10-24 1986-06-30 Sandoz Ag Sulfoxide, verfahren zu ihrer herstellung und ihre verwendung.
ES2038733T3 (es) * 1987-12-04 1993-08-01 Asta Medica Ag Procedimiento para preparar una solucion inyectable de la sal de acido tioctico con trometanol y/o aminoacidos basicos.
JPH03188021A (ja) * 1989-11-09 1991-08-16 Asta Pharma Ag レトロウイルスを撲滅するための医薬品およびその製造法
DE69122264T2 (de) * 1990-11-13 1997-02-06 Iaf Biochem Int Substituierte 1,3-oxathiolane mit antiviralen eigenschaften
FR2676057B1 (fr) * 1991-05-02 1995-03-03 Therapeutique Moder Lab Derives de 1,2-dithiole-3-thione, procede de preparation de ces derives, ainsi que l'utilisation de ces derives comme intermediaires de synthese ou comme medicaments.
US6001555A (en) * 1994-09-23 1999-12-14 The United States Of America As Represented By The Department Of Health And Human Services Method for identifying and using compounds that inactivate HIV-1 and other retroviruses by attacking highly conserved zinc fingers in the viral nucleocapsid protein
US5693460A (en) * 1996-06-24 1997-12-02 Eastman Kodak Company Silver halide photographic elements containing dioxide compunds a stabilizers
EP0855396A1 (fr) * 1997-01-22 1998-07-29 ASTA Medica Aktiengesellschaft Métabolites de l'acide thioctique et leur utilisation

Similar Documents

Publication Publication Date Title
WO1998001440B1 (fr) Compositions pharmaceutiques antivirales contenant des composes 1,2-dithiaheterocycliques satures et utilisation de ces compositions
CA1172633A (fr) Derives de guanine
EP1246625B1 (fr) Compositions des esters de nitrate et leurs utilisation pour sedation
NO158539C (no) Analogifremgangsmaate for fremstilling av en terapeutisk aktiv 2,6-diaminopurinforbindelse.
GB2027024A (en) Doxorubicin derivatives
PT97460A (pt) Processo para a preparacao de compostos anti-virus derivados de acido d-neuraminico e das suas formulacoes farmaceuticas
PT1002792E (pt) Compostos de 2-aminopropano-1,3-diol, sua utilizacao medicinal e intermediariosda sintese dos mesmos
RU97116714A (ru) Композиция селективных ингибиторов вирусных или бактериальных нейраминидаз (варианты), способ лечения или профилактики заболевания гриппом, способ лечения или профилактики вирусных заболевания (варианты)
RU96121572A (ru) Сульфонимидамиды, способ их получения, фармацевтический состав, способ его получения, способ лечения
RU2002124873A (ru) Глюкопиранозилоксибензилбензольные производные, лекарственные композиции, содержащие эти производные, и промежуточные соединения для получения указанных производных
KR930006036A (ko) 퓨린 및 피리미딘의 불포화 비환식 포스포네이트 유도체
ATE195423T1 (de) L-2',3'-dideoxy-nukleosidanaloga als anti- hepatitis b-(hbv) und anti-hiv-wirkstoffe
KR890016966A (ko) 신규 항바이러스제
KR880013937A (ko) 옥세타노신 유도체
GR3000565T3 (en) 2-thiazolyl imidazo û1,2-a¨ pyrimidines and their salts, process for their preparation, their use as medicaments and compositions containing them
KR910000734A (ko) 네플라노신 유도체
ZA872440B (en) Novel-spergualin-related compounds and process for producing the same
ATE92927T1 (de) 1-carboxy-1-vinyloxyiminoaminothiazolcephalosporin-derivate und deren herstellung.
ES469961A1 (es) Procedimiento para la obtencion de nuevos derivados del cro-meno.
KR920005719A (ko) 라브단 및 이의 제조방법
EP0346281B1 (fr) Dérivés d'acide hydroxamique carbamoylé et procédé pour leur préparation
ES2194320T3 (es) Sustancias naturales antivirales o antitumorales y uso de las mismas.
KR970042563A (ko) 새로운 세팔로스포린 유도체 및 그 제조방법
RU2001130750A (ru) Замещенные триптофансодержащие дипептиды с холецистокининонегативной или холецистокининопозитивной активностью
FR2439782A1 (fr) Nouveaux derives a groupe amide ou amine d'anilino-hexahydrobenzo(a)quinolizines substituees en position 2 et medicament les contenant